Jerome Mabie

1.2k total citations
22 papers, 743 citations indexed

About

Jerome Mabie is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Public Health, Environmental and Occupational Health. According to data from OpenAlex, Jerome Mabie has authored 22 papers receiving a total of 743 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Pulmonary and Respiratory Medicine, 7 papers in Oncology and 7 papers in Public Health, Environmental and Occupational Health. Recurrent topics in Jerome Mabie's work include Prostate Cancer Diagnosis and Treatment (8 papers), Reproductive Biology and Fertility (5 papers) and Colorectal Cancer Screening and Detection (5 papers). Jerome Mabie is often cited by papers focused on Prostate Cancer Diagnosis and Treatment (8 papers), Reproductive Biology and Fertility (5 papers) and Colorectal Cancer Screening and Detection (5 papers). Jerome Mabie collaborates with scholars based in United States, Malaysia and United Kingdom. Jerome Mabie's co-authors include Bert Scoccia, Carolyn Westhoff, Emmet J. Lamb, Michelle D. Althuis, Kamran S. Moghissi, Louise A. Brinton, Timothy R. Church, Lawrence R. Ragard, Gerald L. Andriole and Thomas L. Riley and has published in prestigious journals such as Journal of Clinical Oncology, American Journal of Epidemiology and American Journal of Obstetrics and Gynecology.

In The Last Decade

Jerome Mabie

21 papers receiving 726 citations

Peers

Jerome Mabie

PHEOH

ONCOL

PRM

Charlotte Gerd Hannibal Denmark

Berit Jul Mosgaard Denmark

Kyu Ri Hwang South Korea

Amy L. Gross United States

Laura L. Holman United States

Simona Moroni Italy

John Malone United States

Miğraci Tosun Türkiye

Olivier Colomban France

Stefanos Zervoudis Greece

Charlotte Gerd Hannibal Denmark

Jerome Mabie

551 ×1.4

141 ×0.7

PHEOH

266 ×1.5

172 ×1.0

ONCOL

51 ×0.3

PRM

Citations per year, relative to Jerome Mabie Jerome Mabie (= 1×) peers Charlotte Gerd Hannibal

Countries citing papers authored by Jerome Mabie

Since Specialization

Citations

This map shows the geographic impact of Jerome Mabie's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jerome Mabie with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jerome Mabie more than expected).

Fields of papers citing papers by Jerome Mabie

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jerome Mabie. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jerome Mabie. The network helps show where Jerome Mabie may publish in the future.

Co-authorship network of co-authors of Jerome Mabie

This figure shows the co-authorship network connecting the top 25 collaborators of Jerome Mabie. A scholar is included among the top collaborators of Jerome Mabie based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jerome Mabie. Jerome Mabie is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Miller, Eric A., Claire S. Zhu, Neeraj K. Saxena, et al.. (2025). Cohort Profile: The Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial. International Journal of Epidemiology. 54(5).

Khan, Saira, Kathleen Y. Wolin, Ratna Pakpahan, et al.. (2021). Body size throughout the life-course and incident benign prostatic hyperplasia-related outcomes and nocturia. BMC Urology. 21(1). 47–47. 6 indexed citations

Zhu, Claire S., Paul F. Pinsky, James E. Moler, et al.. (2017). Data sharing in clinical trials: An experience with two large cancer screening trials. PLoS Medicine. 14(5). e1002304–e1002304. 6 indexed citations

Mabie, Jerome, Tom Riley, Pamela M. Marcus, et al.. (2015). Data Processing and Analytic Support in the PLCO Cancer Screening Trial. Reviews on Recent Clinical Trials. 10(3). 233–237. 3 indexed citations

Black, Amanda, Wen‐Yi Huang, Patrick Wright, et al.. (2015). PLCO: Evolution of an Epidemiologic Resource and Opportunities for Future Studies. Reviews on Recent Clinical Trials. 10(3). 238–245. 28 indexed citations

Gren, Lisa H., Sheryl Ogden, Jerome Mabie, et al.. (2015). Participants Views of Retention Materials Used in the PLCO Cancer Screening Trial. Clinical Medicine & Research. 13(3-4). 139–148. 1 indexed citations

Marcus, Pamela M., Sheryl Ogden, Lisa H. Gren, et al.. (2014). Non-compliance with the initial screening exam visit in the Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial. Preventive Medicine. 67. 82–88. 5 indexed citations

Humphrey, Peter A., Thomas Hickey, Thomas L. Riley, et al.. (2014). Modified Gleason Grade of Prostatic Adenocarcinomas Detected in the PLCO Cancer Screening Trial. The Journal of Urology. 192(2). 391–395. 1 indexed citations

Wolin, Kathleen Y., Robert L. Grubb, Ratna Pakpahan, et al.. (2014). Physical Activity and Benign Prostatic Hyperplasia-Related Outcomes and Nocturia. Medicine & Science in Sports & Exercise. 47(3). 581–592. 20 indexed citations

10.

Falk, Roni T., Catherine Schairer, Jerome Mabie, et al.. (2014). Alcohol and Risk of Breast Cancer in Postmenopausal Women: An Analysis of Etiological Heterogeneity by Multiple Tumor Characteristics. American Journal of Epidemiology. 180(7). 705–717. 16 indexed citations

11.

Anderson, Kristin E., Steven J. Mongin, Rashmi Sinha, et al.. (2011). Pancreatic cancer risk: Associations with meat‐derived carcinogen intake in the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial (PLCO) cohort. Molecular Carcinogenesis. 51(1). 128–137. 49 indexed citations

12.

Grubb, Robert L., Amanda Black, Grant Izmirlian, et al.. (2009). Serum Prostate-Specific Antigen Hemodilution Among Obese Men Undergoing Screening in the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial. Cancer Epidemiology Biomarkers & Prevention. 18(3). 748–751. 99 indexed citations

13.

Grubb, Robert L., Amanda Black, Timothy R. Church, et al.. (2008). DOES BMI IMPACT PSA CONCENTRATION BY VARIATION IN PLASMA VOLUME?. The Journal of Urology. 179(4S). 703–704. 1 indexed citations

14.

Grubb, Robert L., David L. Levin, Paul F. Pinsky, et al.. (2006). 477: Body Mass Index and Impact on PSA Screening and Prostate Cancer Detection in the Plco Trial. The Journal of Urology. 175(4S). 155–155. 1 indexed citations

15.

Grubb, Robert L., David L. Levin, Paul F. Pinsky, et al.. (2006). 522: Relationship of PSA Velocity and Gleason Score in the PLCO Cancer Screening Trial. The Journal of Urology. 175(4S). 169–169. 2 indexed citations

16.

Brinton, Louise A., Carolyn Westhoff, Bert Scoccia, et al.. (2005). Causes of Infertility as Predictors of Subsequent Cancer Risk. Epidemiology. 16(4). 500–507. 103 indexed citations

17.

Althuis, Michelle D., Bert Scoccia, Emmet J. Lamb, et al.. (2005). Melanoma, thyroid, cervical, and colon cancer risk after use of fertility drugs. American Journal of Obstetrics and Gynecology. 193(3). 668–674. 54 indexed citations

18.

Brinton, Louise A., Emmet J. Lamb, Kamran S. Moghissi, et al.. (2004). Cancer Risk After the Use of Ovulation-Stimulating Drugs. Obstetrical & Gynecological Survey. 59(9). 657–659. 3 indexed citations

19.

Brinton, Louise A., Emmet J. Lamb, Kamran S. Moghissi, et al.. (2004). Ovarian cancer risk associated with varying causes of infertility. Fertility and Sterility. 82(2). 405–414. 162 indexed citations

20.

Brinton, Louise A., Emmet J. Lamb, Kamran S. Moghissi, et al.. (2004). Ovarian Cancer Risk After the Use of Ovulation-Stimulating Drugs. Obstetrics and Gynecology. 103(6). 1194–1203. 114 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact